eFFECTOR Therapeutics, Inc.
EFTR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,811 | -$22,665 | $15,798 | $14,211 |
| Dep. & Amort. | $111 | $53 | $24 | $160 |
| Deferred Tax | $0 | $0 | -$539 | -$333 |
| Stock-Based Comp. | $4,595 | $5,334 | $8,660 | $499 |
| Change in WC | $1,685 | $2,677 | -$238 | -$824 |
| Other Non-Cash | -$130 | -$11,298 | -$48,593 | $122 |
| Operating Cash Flow | -$29,550 | -$25,899 | -$24,888 | $13,835 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$97 | -$192 | -$42 | -$154 |
| Net Acquisitions | $0 | $17,668 | $607 | $0 |
| Inv. Purchases | -$17,169 | -$52,418 | $0 | $0 |
| Inv. Sales/Matur. | $31,750 | $34,750 | $0 | $0 |
| Other Inv. Act. | $0 | -$17,668 | $0 | $0 |
| Investing Cash Flow | $14,484 | -$17,860 | $565 | -$154 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $5,895 | -$2,000 |
| Stock Issued | $21,177 | $2,799 | $56 | $108 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $56 | -$34 | $52,858 | $0 |
| Financing Cash Flow | $21,233 | $2,765 | $58,809 | -$1,892 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $6,167 | -$40,994 | $34,486 | $11,789 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,708 | $49,702 | $15,216 | $3,427 |
| End Cash | $14,875 | $8,708 | $49,702 | $15,216 |
| Free Cash Flow | -$29,647 | -$26,091 | -$24,930 | $13,681 |